Simplex Trading’s Apexigen APGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-21,200
Closed -$9K – 10286
2023
Q2
$9K Buy
+21,200
New +$10K ﹤0.01% 7545
2022
Q4
– Sell
-500
Closed -$1K – 10865
2022
Q3
$1K Buy
+500
New +$4.07K ﹤0.01% 9731

Simplex Trading's APGN Position: Q3 2023 in Review

Simplex Trading sold out of Apexigen (APGN) in Q3 2023, closing a stake of 3,308 shares — an estimated $1K sold.

Simplex Trading first reported a position in APGN in Q3 2022 and held it in 3 quarters. The position peaked at $1K in Q2 2023. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

  • Simplex Trading reported no remaining Apexigen position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 3,308 Apexigen shares in Q3 2023, an estimated $1K.
  • Simplex Trading first reported a position in Apexigen in Q3 2022 and held it in 3 quarters.
  • Simplex Trading's Apexigen position peaked at $1K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Apexigen as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.